phenytoin has been researched along with metyrapone in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (78.57) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (21.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brooks, MH; Lawrence, AM; Paloyan, E; Prinz, RA | 1 |
Marshall, JS; Tompkins, LS | 1 |
Choi, Y; Sholiton, LJ; Thrasher, K; Werk, EE | 1 |
Rinne, UK | 1 |
Asfeldt, VH; Buhl, J | 1 |
Jubiz, W; Matsukura, S; Meikle, AW; Tyler, FH; West, CD | 1 |
Jubiz, W; Levinson, RA; Meikle, AW; Tyler, FH; West, CD | 1 |
Jubiz, W; Meikle, AW; Tyler, FH; West, CD | 1 |
Garattini, S; Szalay, KS; Szeberenyi, S | 1 |
Garattini, S; Szeberenyi, S; Tacconi, MT | 1 |
Elias, AN; Gwinup, G | 1 |
2 review(s) available for phenytoin and metyrapone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Effects of some clinically encountered drugs on steroid synthesis and degradation.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aminoglutethimide; Animals; Drug Interactions; Ethanol; Fetus; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Hydrocortisone; Hydroxycholecalciferols; Liver; Metyrapone; Mitotane; Phenobarbital; Phenytoin; Rifampin; Spironolactone; Steroids | 1980 |
12 other study(ies) available for phenytoin and metyrapone
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
The continued importance of adrenalectomy in the treatment of Cushing's disease.
Topics: Adolescent; Adrenalectomy; Adult; Cushing Syndrome; Cyproheptadine; Female; Humans; Hypophysectomy; Male; Metyrapone; Middle Aged; Mitotane; Phenytoin; Radiotherapy | 1979 |
Effect of o,p'-DDD and similar compounds on thyroxine binding globulin.
Topics: Alpha-Globulins; Autoradiography; Blood Protein Electrophoresis; Cellulose; Dichlorodiphenyldichloroethane; Humans; Metyrapone; Phenytoin; Pituitary-Adrenal Function Tests; Protein Binding; Thyroxine-Binding Proteins | 1968 |
Failure of metyrapone to inhibit 11-hydroxylation of 11-deoxycortisol during drug therapy.
Topics: 17-Hydroxycorticosteroids; Adrenal Glands; Adrenocorticotropic Hormone; Chromatography, Paper; Chromatography, Thin Layer; Cushing Syndrome; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Metyrapone; Phenobarbital; Phenytoin; Pituitary Function Tests; Secretory Rate; Steroids | 1967 |
Site of the inhibiting action of diphenylhydantoin on the release of corticotrophin in epileptic patients.
Topics: 17-Hydroxycorticosteroids; Adrenal Glands; Adrenocorticotropic Hormone; Epilepsy, Tonic-Clonic; Female; Humans; Hypothalamo-Hypophyseal System; Male; Metyrapone; Phenytoin; Pituitary Gland; Vasopressins | 1967 |
Inhibitory effect of diphenylhydantoin on the feedback control of corticotrophin release.
Topics: 17-Hydroxycorticosteroids; Adolescent; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Circadian Rhythm; Depression, Chemical; Dexamethasone; Epilepsy; Feedback; Female; Humans; Hypothalamo-Hypophyseal System; Male; Metyrapone; Middle Aged; Phenytoin; Pituitary-Adrenal System | 1969 |
Effect of diphenylhydantoin on the metabolism of metyrapone and release of ACTH in man.
Topics: 17-Hydroxycorticosteroids; Adrenocorticotropic Hormone; Depression, Chemical; Epilepsy; Humans; Hydrocortisone; Intestinal Absorption; Metyrapone; Mixed Function Oxygenases; Phenytoin; Pyrogens; Tritium | 1969 |
Absorption and conjugation of metyrapone during diphenylhydantoin therapy: mechanism of the abnormal response to oral metyrapone.
Topics: 17-Hydroxycorticosteroids; Adrenocorticotropic Hormone; Animals; Biotransformation; Enzyme Induction; Intestinal Absorption; Liver; Male; Metyrapone; Microscopy, Electron; Microsomes; Mixed Function Oxygenases; Phenytoin; Portal Vein; Rats; Vena Cava, Superior | 1970 |
Dilantin and metyrapone: a clinically significant example of enzyme induction.
Topics: 17-Hydroxycorticosteroids; Adrenocorticotropic Hormone; Animals; Depression, Chemical; Endoplasmic Reticulum; Enzyme Induction; Epilepsy; Estrogens; Glucuronates; Humans; Hyperplasia; Hypopituitarism; Liver; Metyrapone; Mixed Function Oxygenases; Phenobarbital; Phenytoin; Pituitary Function Tests; Pyrogens; Rats | 1970 |
Removal of plasma metyrapone in rats submitted to previous pharmacological treatment.
Topics: Animals; Diazepam; Female; Hydrocortisone; Liver; Meprobamate; Metyrapone; Nikethamide; Pentaerythritol Tetranitrate; Phenobarbital; Phenylbutazone; Phenytoin; Rats | 1969 |
Increased metabolism of metyrapone in rats pretreated with diphenylhydantoin or phenobarbital.
Topics: Adrenal Glands; Animals; Biotransformation; Chromatography, Thin Layer; Enzyme Induction; Epilepsy; Liver; Metyrapone; Microsomes; Phenobarbital; Phenytoin; Pituitary Function Tests; Rats; Stimulation, Chemical | 1969 |